Evidence map›Paper›PMID 41867769›Full record

ArticlebioRxiv : the preprint server for biology2026

TGFβ signaling systems are prone to inhibition and ligand competition by coreceptor.

Wisam A Fares, Kevin A Janes

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Wisam A FaresDepartment of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, U.S.A.
Kevin A JanesDepartment of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, U.S.A.ORCID 0000-0002-8028-6138

Funding

Women's Oncology Program - WONP30CA044579 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Dina Gould Halme · 1987 to 2026
$72.1M
Cancer Research Training Program: From Molecular Mechanisms to Therapeutic StrategiesT32CA009109 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Andrew Carl Dudley, Melanie R Rutkowski · 1985 to 2026
$13.9M
Systems Analysis of Stress-adapted Cancer Organelles (SASCO) CenterU54CA274499 · NCI · UNIVERSITY OF VIRGINIA · PI Kevin A Janes, Matthew J Lazzara · 2022 to 2026
$13.4M
Heterogeneous Loss of GDF11 Tumor Suppression in Triple-negative Breast CancerR01CA214718 · NCI · UNIVERSITY OF VIRGINIA · PI JANES, KEVIN A · 2018 to 2022
$1.8M
In silico modeling of subcellular infection by diverse families of RNA virusR01AI186222 · NIAID · UNIVERSITY OF VIRGINIA · PI Kevin A Janes · 2024 to 2026
$1.6M
NCI NIH HHS P30 CA044579NCI NIH HHS R01 CA214718NCI NIH HHS T32 CA009109NCI NIH HHS U54 CA274499NIAID NIH HHS R01 AI186222
6 · The paper itself

Abstract

Transforming growth factor-β (TGFβ) ligands and receptors interact with overlapping selectivity to form different signaling complexes. This many-to-many wiring provides versatility in how ligands are perceived and cell types become activated, but the systems-level impact of coreceptors, which bind TGFβ ligands yet do not signal, remains unresolved. We examined the role of canonical surface-bound coreceptors by numerically simulating TGFβ ligand-receptor systems of increasing complexity and pairing results with single-cell measurements in acutely stimulated cells. Using sampled combinations of biologically plausible rate parameters and initial conditions, we find that coreceptors inhibit downstream signaling six times more often than they promote it, and the models reconcile this inhibitory bias with the prevailing view that coreceptors either promote or inhibit signaling. In multi-ligand systems, coreceptor inhibition causes stimuli to be perceived differently by altering competition, and this threshold is confirmed in cells engineered to induce a single coreceptor heterogeneously. Coreceptors are among the most variably expressed components of TGFβ signaling, suggesting that cells exploit coreceptors as a way to switch active ligand-receptor landscapes with a single gene.

Indexed as

betaglycanendoglinENGGDF11growth differentiation factor 11TGFBR3

Identifiers

PMID41867769
PMCPMC13001335

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.